LV10255B - N-substituted heterocyclic compounds, method of preparation thereof and pharmaceutical composition comprising thereof - Google Patents
N-substituted heterocyclic compounds, method of preparation thereof and pharmaceutical composition comprising thereofInfo
- Publication number
- LV10255B LV10255B LVP-92-109A LV920109A LV10255B LV 10255 B LV10255 B LV 10255B LV 920109 A LV920109 A LV 920109A LV 10255 B LV10255 B LV 10255B
- Authority
- LV
- Latvia
- Prior art keywords
- preparation
- pharmaceutical composition
- substituted heterocyclic
- heterocyclic compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9111161A FR2681067B1 (fr) | 1991-09-10 | 1991-09-10 | Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10255A LV10255A (lv) | 1994-10-20 |
| LV10255B true LV10255B (en) | 1995-04-20 |
Family
ID=9416798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-92-109A LV10255B (en) | 1991-09-10 | 1992-09-04 | N-substituted heterocyclic compounds, method of preparation thereof and pharmaceutical composition comprising thereof |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0532410A1 (fr) |
| JP (1) | JPH05213894A (fr) |
| KR (1) | KR930006008A (fr) |
| AU (1) | AU661017B2 (fr) |
| CA (1) | CA2077967A1 (fr) |
| CZ (1) | CZ275992A3 (fr) |
| FR (1) | FR2681067B1 (fr) |
| HU (1) | HUT63616A (fr) |
| IL (1) | IL103116A (fr) |
| LT (1) | LT3148B (fr) |
| LV (1) | LV10255B (fr) |
| MX (1) | MX9205155A (fr) |
| MY (1) | MY108089A (fr) |
| NO (1) | NO180678C (fr) |
| NZ (1) | NZ244258A (fr) |
| PL (1) | PL171524B1 (fr) |
| RU (1) | RU2107062C1 (fr) |
| TW (1) | TW218871B (fr) |
| ZA (1) | ZA926899B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69131021T2 (de) * | 1990-12-14 | 1999-08-12 | Smithkline Beecham Corp | Angiotensin-ii-rezeptor blockierende zusammensetzungen |
| US5484939A (en) * | 1993-03-12 | 1996-01-16 | Lonza Ltd. | 2-substituted 5-chlorimidazoles |
| US5721263A (en) * | 1993-06-07 | 1998-02-24 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for angiotensin II-mediated diseases |
| HU218681B (hu) | 1997-07-25 | 2000-10-30 | Sanofi-Synthelabo | Eljárás 1,3-diaza-spiro(4,4)non-1-én-4-on-származékok előállitására és 1-ciano-1-(acil-amino)-ciklopentán intermedierek |
| HU218680B (hu) | 1997-07-25 | 2000-10-30 | Sanofi-Synthelabo | Eljárás 1,3-diaza-spiro[4,4]non-1-én-4-on-származékok előállítására és 1-ciano-1-(acil-amino)-ciklopentán intermedierek |
| AU767456B2 (en) | 1998-07-06 | 2003-11-13 | Bristol-Myers Squibb Company | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| US6638937B2 (en) | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| BRPI0406987A (pt) | 2003-01-31 | 2006-01-10 | Sankyo Co | Medicamento para a prevenção e/ou tratamento de arteriosclerose, medicamentos para a inibição de proliferação de células do músculo liso vascular, de formação de neoìntima dos vasos sanguìneos e de remodelação vascular, medicamento para a prevenção de restenose que segue intervenção coronária percutânea, e, medicamentos para a profilaxia e/ou tratamento de hipertensão ou doenças causadas por hipertensão ou doenças causadas por hipertensão, de doenças cardìacas, de angina do peito, de infarto miocárdico, de arritmia, de morte súbita, de insuficiência cardìaca, de hipertrofia cardìaca, de doenças renais, de nefropatia diabética, de glomerulonefrite, de nefrosclerose, de doenças cerebrovasculares, de infarto cerebral, e de hemorragia cerebral |
| ATE493973T1 (de) | 2004-06-04 | 2011-01-15 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
| AP2007004161A0 (en) * | 2005-04-28 | 2007-10-31 | Pfizer Ltd | Amino acid derivatives |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP3239170B1 (fr) | 2008-06-04 | 2019-03-20 | Synergy Pharmaceuticals Inc. | Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles |
| EP3241839B1 (fr) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (fr) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions utiles pour le traitement de troubles gastro-intestinaux |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH540271A (de) | 1970-05-29 | 1973-08-15 | Agripat Sa | Verfahren zur Herstellung neuer, herbizid wirksamer s-Triazine und deren Verwendung zur Bekämpfung von Unkräutern |
| US4017510A (en) | 1975-11-12 | 1977-04-12 | American Cyanamid Company | Imidazoisoindolediones and the use thereof as herbicidal agents |
| DE3545597A1 (de) * | 1985-12-21 | 1987-07-02 | Celamerck Gmbh & Co Kg | Neue herbizid wirksame imidazolinone |
| EP0303863A3 (fr) * | 1987-08-17 | 1991-10-23 | American Cyanamid Company | Composés de benzène sulfonyl carboxamide, composés intermédiaires et procédés pour leur préparation et l'utilisation de ces composés et intermédiaires comme herbicides |
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| CA2020073A1 (fr) * | 1989-07-03 | 1991-01-04 | Eric E. Allen | Quinazolinones substitues comme antagonistes de l'angiotensine ii |
| DE69024556T2 (de) * | 1989-07-28 | 1996-10-17 | Merck & Co Inc | Substituierte Triazolinone, Triazolinthione und Triazolinimine als Angiotensin II-Antagonisten |
| IL99372A0 (en) * | 1990-09-10 | 1992-08-18 | Ciba Geigy Ag | Azacyclic compounds |
| JP2004247578A (ja) | 2003-02-14 | 2004-09-02 | Kawasaki Microelectronics Kk | 半導体装置および半導体装置の製造方法 |
-
1991
- 1991-09-10 FR FR9111161A patent/FR2681067B1/fr not_active Expired - Fee Related
-
1992
- 1992-08-26 TW TW081106738A patent/TW218871B/zh active
- 1992-09-04 CZ CS922759A patent/CZ275992A3/cs unknown
- 1992-09-04 MY MYPI92001566A patent/MY108089A/en unknown
- 1992-09-04 LV LVP-92-109A patent/LV10255B/xx unknown
- 1992-09-08 LT LTIP119A patent/LT3148B/lt not_active IP Right Cessation
- 1992-09-08 NZ NZ244258A patent/NZ244258A/en unknown
- 1992-09-09 KR KR1019920016618A patent/KR930006008A/ko not_active Application Discontinuation
- 1992-09-09 RU SU5052773A patent/RU2107062C1/ru active
- 1992-09-09 HU HU9202889A patent/HUT63616A/hu unknown
- 1992-09-09 IL IL103116A patent/IL103116A/en not_active IP Right Cessation
- 1992-09-09 PL PL92295874A patent/PL171524B1/pl unknown
- 1992-09-09 NO NO923509A patent/NO180678C/no unknown
- 1992-09-09 EP EP92402459A patent/EP0532410A1/fr not_active Withdrawn
- 1992-09-09 MX MX9205155A patent/MX9205155A/es unknown
- 1992-09-10 JP JP4242126A patent/JPH05213894A/ja not_active Withdrawn
- 1992-09-10 ZA ZA926899A patent/ZA926899B/xx unknown
- 1992-09-10 AU AU22868/92A patent/AU661017B2/en not_active Ceased
- 1992-09-10 CA CA002077967A patent/CA2077967A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO180678B (no) | 1997-02-17 |
| MY108089A (en) | 1996-08-15 |
| LTIP119A (en) | 1994-07-15 |
| NO923509L (no) | 1993-03-11 |
| PL171524B1 (pl) | 1997-05-30 |
| ZA926899B (en) | 1993-03-16 |
| HUT63616A (en) | 1993-09-28 |
| RU2107062C1 (ru) | 1998-03-20 |
| CZ275992A3 (en) | 1993-03-17 |
| JPH05213894A (ja) | 1993-08-24 |
| AU2286892A (en) | 1993-03-11 |
| NO180678C (no) | 1997-05-28 |
| MX9205155A (es) | 1993-03-01 |
| FR2681067B1 (fr) | 1993-12-17 |
| NO923509D0 (no) | 1992-09-09 |
| PL295874A1 (en) | 1993-04-19 |
| TW218871B (fr) | 1994-01-11 |
| CA2077967A1 (fr) | 1993-03-11 |
| KR930006008A (ko) | 1993-04-20 |
| IL103116A (en) | 1998-04-05 |
| NZ244258A (en) | 1996-10-28 |
| FR2681067A1 (fr) | 1993-03-12 |
| LT3148B (en) | 1995-01-31 |
| IL103116A0 (en) | 1993-02-21 |
| HU9202889D0 (en) | 1992-11-30 |
| EP0532410A1 (fr) | 1993-03-17 |
| AU661017B2 (en) | 1995-07-13 |
| LV10255A (lv) | 1994-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL102638A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL103053A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| SI1156049T1 (en) | Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them | |
| PL299176A1 (en) | Novel heterocyclic compounds, pharmaceutical agent, method of obtaining such novel heterocyclic compounds and initial compounds for obtaining them | |
| GR3025940T3 (en) | Heterocyclic derivatives of acylaminothiazole, their preparation and pharmaceutical compositions containing them. | |
| HUT72639A (en) | Substituted thiazolidinedione derivatives, pharmaceutical compositions containing them and process for their preparation | |
| LTIP656A (en) | Derivatives of 3-amidopyrazole, process for preparing thereof and pharmaceutical composition containing them | |
| LV10255B (en) | N-substituted heterocyclic compounds, method of preparation thereof and pharmaceutical composition comprising thereof | |
| NZ224347A (en) | Heterocyclic compounds and pharmaceutical compositions | |
| IL112443A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
| IL108800A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
| IL114534A (en) | Heterocyclic derivatives of azolones their preparation and pharmaceutical compositions containing them | |
| IL106385A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| CZ92295A3 (en) | Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof | |
| CZ346595A3 (en) | Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof | |
| IL106041A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL106549A0 (en) | Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them | |
| IL101164A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL99561A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL103698A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL101165A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL123424A0 (en) | Heterocyclic compounds their preparation and pharmaceutical compositions containing them | |
| IL116245A0 (en) | Heterocyclic amides their preparation and pharmaceutical compositions containing them | |
| IL100689A0 (en) | Amide derivatives,their preparation and pharmaceutical compositions containing them | |
| ZA912072B (en) | N-substituted heterocyclic derivatives,their preparation and pharmaceutical compositions containing them |